Compare SLS & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLS | MFM |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 223.2M |
| IPO Year | N/A | N/A |
| Metric | SLS | MFM |
|---|---|---|
| Price | $2.03 | $5.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 108.1K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $176.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $4.37 |
| 52 Week High | $2.48 | $5.48 |
| Indicator | SLS | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 50.98 |
| Support Level | $1.39 | $5.40 |
| Resistance Level | $2.00 | $5.47 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 89.73 | 57.09 |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.